Calendar NovaBay Pharmaceuticals, Inc.

Equities

NBY

US66987P3001

Market Closed - Nyse 04:00:00 2024-05-31 pm EDT 5-day change 1st Jan Change
3.44 USD -5.68% Intraday chart for NovaBay Pharmaceuticals, Inc. -25.43% -51.82%

Chart calendar NovaBay Pharmaceuticals, Inc.

d532daf6ad07964fcc.Ec7zPOIUztYvNRDG0Qdf9UAsCGYTHldZ3_0EkaXqrtU.YJ25S7hZtoZEACathl00xwddTBdjbi4Thqhd-MmP5OZ1noJri26th2JWYw~44c9ad8445d376a51b6753329765102d

Upcoming events on NovaBay Pharmaceuticals, Inc.

2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)

Past events on NovaBay Pharmaceuticals, Inc.

2024-05-28 02:00 pm Annual General Meeting
2024-05-09 04:30 pm Q1 2024 Earnings Call
2024-05-09 04:05 pm Q1 2024 Earnings Release
2024-03-26 04:30 pm Q4 2023 Earnings Call
2024-03-26 04:05 pm Q4 2023 Earnings Release
2022-11-15 Reverse Split: 1 of 35
2022-08-11 04:30 pm Interim 2022 Earnings Call
2022-08-11 04:05 pm Interim 2022 Earnings Release
2022-05-12 04:30 pm Q1 2022 Earnings Call
2022-05-12 04:05 pm Q1 2022 Earnings Release
2022-03-29 04:30 pm FY 2021 Earnings Call
2022-03-29 04:05 pm FY 2021 Earnings Release
2022-01-31 02:00 pm Extraordinary Shareholders Meeting - Third Call
2022-01-13 Extraordinary Shareholders Meeting - Second Call
2022-01-10 07:00 am H.C. Wainwright BioConnect Conference
2021-12-16 Extraordinary Shareholders Meeting - First Call
2021-11-11 04:30 pm Q3 2021 Earnings Call
2021-11-11 04:05 pm Q3 2021 Earnings Release
2021-09-29 04:30 pm Acquisition of DERMAdoctor, LLC by NovaBay® Pharmaceuticals, Inc Call
2021-09-12 H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
6,60
6,97
-5.32%
9,93
10,5
-5.39%
8,42
9,14
-7.82%
14,4
14,2
1.22%
14,7
14,4
2.26%

14,8

EBITDA
Million USD
Released
Forecast
Spread
-9,34
-8,30
-12.47%
-6,38
-5,70
-11.84%
-8,74
-6,80
-28.57%
-7,20
-4,50
-59.93%
-7,39
-5,50
-34.42%

-2,60

EBIT
Million USD
Released
Forecast
Spread
-9,40
-8,99
-4.56%
-6,43
-6,48
0.76%
-8,86
-8,59
-3.17%
-7,68
-5,76
-33.33%
-7,60
-6,20
-22.52%

-3,35

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-9,65
-8,79
-9.81%
-11,0
-11,1
0.86%
-5,82
-8,59
32.16%
-10,6
-5,97
-77.84%
-9,64
-9,50
-1.47%

-3,35

Net income
Million USD
Released
Forecast
Spread
-10,5
-8,80
-19.24%
-11,0
-11,1
0.82%
-6,56
-8,59
23.6%
-16,3
-5,97
-172.67%
-16,7
-9,50
-75.76%

-3,35

EPS
USD
Released
Forecast
Spread
-588
-521
-12.94%
-380
-392
3.12%
-184
-221
16.67%
-353
-142
-149.38%
-139
-80,9
-71.43%

-9,45

Announcement Date26/03/2025/03/2129/03/2230/03/2326/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
2,63
3,26
-19.36%
3,05
3,51
-13.25%
3,83
3,74
2.3%
3,64
4,73
-22.98%
3,12
3,20
-2.38%
4,61
3,68
25.44%
3,27
3,55
-7.9%
3,73
3,40
9.62%
2,63
3,28
-19.79%

3,58


3,71


4,24


4,39


4,78

EBITDA
Million USD
Released
Forecast
Spread
-2,35
-3,10
24.13%
-2,03
-2,30
11.65%
-0,34
-1,30
74%
-2,57
0,00
-
-1,68
-1,80
6.5%
-1,30
-1,60
18.5%
-1,07
-1,40
23.93%
-3,34
-1,60
-108.81%
-2,42
-1,10
-120.36%

-0,90


-0,50


-0,20


0,10


0,10

EBIT
Million USD
Released
Forecast
Spread
-2,38
-2,90
17.72%
-2,15
-2,53
14.94%
-0,46
-1,95
76.56%
-2,69
-0,76
-253.82%
-1,73
-2,10
17.43%
-1,36
-2,09
35.17%
-1,12
-1,65
32.16%
-3,39
-2,00
-69.55%
-2,44
-1,32
-84.55%

-1,08


-0,71


-0,24


-0,36


-0,11

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-0,11
-2,15
94.83%
-2,16
-2,38
9.45%
-0,14
-1,80
92.44%
-8,21
-0,76
-979.74%
-1,74
-2,10
17.19%
-2,04
-2,09
2.58%
-1,76
-1,65
-6.81%
-4,11
-2,00
-105.4%
-3,09
-1,32
-134.09%

-1,08


-0,71


-0,24


-0,36


-0,11

Net income
Million USD
Released
Forecast
Spread
-0,11
-2,15
94.83%
-2,16
-2,38
9.45%
-5,79
-1,80
-221.83%
-8,21
-0,76
-979.74%
-1,74
-2,10
17.19%
-4,03
-2,09
-92.92%
-1,76
-1,65
-6.81%
-9,17
-2,00
-358.45%
-3,59
-1,32
-172.27%

-1,08


-0,71


-0,24


-0,36


-0,11

EPS
USD
Released
Forecast
Spread
0,00
-36,8
-
-49,0
-42,9
-14.29%
-123
-36,8
-233.33%
-152
-12,8
-1086.3%
-29,8
-31,9
6.59%
-44,5
-19,4
-128.83%
-13,0
-14,2
8.64%
-46,6
-10,5
-343.33%
-5,25
-5,25
0%

-3,15


-2,10


-0,35


-0,88


0,00

Announcement Date12/05/2211/08/2214/11/2230/03/2311/05/2310/08/2309/11/2326/03/2409/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NBY Stock
  4. Calendar NovaBay Pharmaceuticals, Inc.